TRIANA Biomedicines

TRIANA Biomedicines is developing molecular glue therapeutics initially tailored for targeted protein degradation applications. TRIANA is building its pipeline using a target-first, rational approach to molecular glue discovery, and aspires to develop products for a wide range of therapeutic applications.

Headquarters Waltham, MA
Pipeline Preclinical
Twitter @Triana_Bio‚Äč
LinkedIn TRIANA Biomedicines